3 employees
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.
2009
$5.5M
from 1 investors over 1 rounds
KinDex Pharmaceuticals, Inc. raised $5.5M on March 9, 2015
Investors: Polaris Partners